The global endobronchial valves market is experiencing steady growth due to the rising prevalence of chronic respiratory disorders such as chronic obstructive pulmonary disease (COPD) and emphysema. Endobronchial valves are minimally invasive medical devices placed in the airways through bronchoscopy to reduce lung hyperinflation and improve breathing in patients suffering from severe lung conditions. These devices help redirect airflow by blocking damaged portions of the lungs, allowing healthier areas to function more effectively and enhancing the patient’s overall respiratory capacity.

According to recent industry insights, the global endobronchial valves market was valued at USD 190.64 million in 2025 and is projected to reach USD 321.53 million by 2034, registering a CAGR of 6.0% during the forecast period. The increasing burden of respiratory diseases, technological advancements in bronchoscopic procedures, and growing adoption of minimally invasive treatment options are expected to drive market expansion over the coming years.

Market Overview

Endobronchial valves are small implantable devices designed to treat severe emphysema and other chronic respiratory conditions by reducing lung volume and improving airflow. These valves are inserted using bronchoscopic techniques, eliminating the need for traditional surgical procedures. This minimally invasive approach reduces recovery time and offers a safer treatment alternative for patients who may not be suitable candidates for lung surgery.

The growing prevalence of respiratory diseases worldwide is a major factor driving demand for these devices. COPD remains one of the leading causes of mortality globally, with millions of individuals suffering from breathing difficulties and reduced lung function. Increasing clinical research and trials evaluating the effectiveness of endobronchial valve therapies are further supporting their adoption in the healthcare sector.

Key Market Growth Drivers

Rising Prevalence of COPD and Emphysema

One of the primary factors driving the growth of the endobronchial valves market is the increasing global burden of respiratory diseases. COPD affects millions of people worldwide and is responsible for a substantial number of deaths each year. Patients suffering from severe emphysema often experience lung hyperinflation and breathing difficulties, making them ideal candidates for endobronchial valve therapy. The growing patient pool is therefore significantly boosting the demand for these devices.

Growing Adoption of Minimally Invasive Procedures

Healthcare providers are increasingly adopting minimally invasive treatment options to improve patient outcomes and reduce hospital stays. Endobronchial valve placement is performed using bronchoscopy, a less invasive technique compared to traditional lung surgery. This procedure offers faster recovery, fewer complications, and improved patient comfort, making it an attractive treatment option for both physicians and patients.

Market Challenges

Despite its promising growth prospects, the endobronchial valves market faces several challenges.

One major limitation is the high cost of treatment procedures and specialized devices, which may restrict adoption in low- and middle-income regions. Additionally, the procedure requires highly trained pulmonologists and specialized healthcare facilities, limiting accessibility in some developing countries.

Another challenge involves potential complications associated with valve implantation, such as pneumothorax, infection, or COPD exacerbations in certain patients. These risks require careful patient selection and monitoring, which may limit the widespread use of the technology.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 @

https://www.polarismarketresearch.com/industry-analysis/endobronchial-valves-market

Key Companies

• Boston Scientific Corporation
• Broncus Medical
• EndoStim
• Olympus Corporation
• PneumRx
• Pulmonx Corporation
• Spiration Inc.

Market Segmentation

The endobronchial valves market is segmented based on product type, end user, and region.

Endobronchial Valves, Product Type Outlook (Revenue - USD Million, 2021 - 2034)

• Duckbill-shaped
• Umbrella-shaped

Endobronchial Valves, End User Outlook (Revenue - USD Million, 2021 - 2034)

• Hospitals
• Clinical Research Center
• Ambulatory Surgery Center
• Others

Conclusion

The global endobronchial valves market is poised for steady growth as the burden of respiratory diseases continues to rise worldwide. Increasing adoption of minimally invasive pulmonary procedures, advancements in bronchoscopic technologies, and growing clinical evidence supporting valve therapies are expected to drive market expansion.

More Trending Latest Reports By Polaris Market Research:

Retail Automation Market

RegTech Market

Smart Glass Market

U.S. Analytical Instrumentation Market

US Human Growth Hormone Market

Tissue Diagnostics Market

Medical Aesthetics Market

Electrical and Electronic Adhesive Market

Waste Management Market